Skip to main
CAH

Cardinal Health (CAH) Stock Forecast & Price Target

Cardinal Health (CAH) Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 33%
Buy 58%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

Cardinal Health is forecasted to continue its growth trajectory due to its strong positioning in the pharmaceutical industry and increasing demand for specialty drugs. With a focus on sustainability and its leading distribution and technology services, the company is expected to outperform its competitors. Additionally, Cardinal Health's solid financial standing sets it up for continued success and potential for further expansion and innovation in the future.

Bears say

Cardinal Health is facing potential regulatory hurdles and risks in its Nuclear & Precision Health Solutions segment, as well as challenges in implementing automation and increasing specialty drug penetration. However, it has a strong distribution platform and is expanding its services and collaborations to mitigate potential impacts from changes in reimbursement and fulfillment models. The company is also returning capital to shareholders and has a strong financial position, but its future growth will depend heavily on its ability to execute its turnaround plan and successfully spin off its GMPD business.

Cardinal Health (CAH) has been analyzed by 12 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 58% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cardinal Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cardinal Health (CAH) Forecast

Analysts have given Cardinal Health (CAH) a Buy based on their latest research and market trends.

According to 12 analysts, Cardinal Health (CAH) has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $270.58, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $270.58, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cardinal Health (CAH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.